Profound Medical (PROF) News Today $6.68 -0.13 (-1.91%) As of 03:59 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Save the Date: Profound Medical to Host Investor Event at AUA 2025March 25 at 8:10 AM | financialpost.comRaymond James Financial Inc. Acquires Shares of 875,709 Profound Medical Corp. (NASDAQ:PROF)Raymond James Financial Inc. acquired a new stake in Profound Medical Corp. (NASDAQ:PROF - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 875,709 shares of the company's stock, valued at approximatMarch 24 at 3:15 AM | marketbeat.comRosalind Advisors Inc. Has $5.20 Million Stake in Profound Medical Corp. (NASDAQ:PROF)Rosalind Advisors Inc. lifted its stake in shares of Profound Medical Corp. (NASDAQ:PROF - Free Report) by 42.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 692,185 shares of the company's stock afMarch 23 at 5:49 AM | marketbeat.comMagnetar Financial LLC Makes New $3.83 Million Investment in Profound Medical Corp. (NASDAQ:PROF)Magnetar Financial LLC purchased a new stake in shares of Profound Medical Corp. (NASDAQ:PROF - Free Report) during the 4th quarter, according to the company in its most recent filing with the SEC. The fund purchased 509,400 shares of the company's stock, valued at approximately $3,826,000. MagnetaMarch 22 at 5:20 AM | marketbeat.comPROF Investors Have Opportunity to Join Profound Medical Corp. Fraud Investigation with the Schall Law FirmMarch 21, 2025 | businesswire.comRoyce & Associates LP Raises Stock Holdings in Profound Medical Corp. (NASDAQ:PROF)Royce & Associates LP boosted its stake in Profound Medical Corp. (NASDAQ:PROF - Free Report) by 34.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 764,799 shares of the company's stock aMarch 20, 2025 | marketbeat.comVestcor Inc Acquires New Holdings in Profound Medical Corp. (NASDAQ:PROF)Vestcor Inc bought a new position in shares of Profound Medical Corp. (NASDAQ:PROF - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 50,000 shares of the company's stock, valMarch 18, 2025 | marketbeat.comProfound Medical Corp. (NASDAQ:PROF) Sees Large Growth in Short InterestProfound Medical Corp. (NASDAQ:PROF - Get Free Report) saw a significant increase in short interest in the month of February. As of February 28th, there was short interest totalling 474,700 shares, an increase of 23.9% from the February 13th total of 383,200 shares. Based on an average daily volume of 90,300 shares, the days-to-cover ratio is presently 5.3 days. Approximately 1.6% of the shares of the company are sold short.March 18, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROFMarch 17, 2025 | prnewswire.comPicton Mahoney Asset Management Purchases New Holdings in Profound Medical Corp. (NASDAQ:PROF)Picton Mahoney Asset Management purchased a new stake in Profound Medical Corp. (NASDAQ:PROF - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 250,000 shares of the company's stock, valued at approximately $1,879,000. Picton Mahoney AMarch 17, 2025 | marketbeat.comProfound Medical Corp. (PROF) Investors Who Lost Money - Contact Law Offices of Howard G. Smith About Securities Fraud InvestigationMarch 13, 2025 | tmcnet.comSecurities Fraud Investigation Into Profound Medical Corp. (PROF) Announced – Investors Who Lost Money Urged to Contact The Law Offices of Frank R. CruzMarch 12, 2025 | businesswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROFMarch 11, 2025 | prnewswire.comProfound Medical Corp. (NASDAQ:PROF) Q4 2024 Earnings Call TranscriptMarch 10, 2025 | msn.comProfound Medical (NASDAQ:PROF) Posts Earnings Results, Beats Estimates By $0.11 EPSProfound Medical (NASDAQ:PROF - Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.20) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.31) by $0.11. Profound Medical had a negative net margin of 349.41% and a negative return on equity of 85.22%.March 7, 2025 | marketbeat.comProfound Medical Corporation (PROF) Q4 2024 Earnings Conference Call TranscriptMarch 6, 2025 | seekingalpha.comTruist Financial Corp Buys Shares of 50,000 Profound Medical Corp. (NASDAQ:PROF)Truist Financial Corp bought a new stake in shares of Profound Medical Corp. (NASDAQ:PROF - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 50,000 shares of the company'sMarch 5, 2025 | marketbeat.com277,859 Shares in Profound Medical Corp. (NASDAQ:PROF) Bought by Ring Mountain Capital LLCRing Mountain Capital LLC bought a new position in shares of Profound Medical Corp. (NASDAQ:PROF - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 277,859 shares of the company's stock, valuedMarch 4, 2025 | marketbeat.comProfound Medical (PROF) Projected to Post Quarterly Earnings on ThursdayProfound Medical (NASDAQ:PROF) will be releasing earnings after the market closes on Thursday, March 6, Financial Modeling Prep reports.February 27, 2025 | marketbeat.comProfound Medical Standardizes on AcuityMD Intelligence Platform for MedTech as Foundation for Growing OrganizationFebruary 26, 2025 | tmcnet.com490,000 Shares in Profound Medical Corp. (NASDAQ:PROF) Bought by MMCAP International Inc. SPCMMCAP International Inc. SPC acquired a new position in Profound Medical Corp. (NASDAQ:PROF - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 490,000 shares of the company's stock, valuFebruary 26, 2025 | marketbeat.comThompson Davis & CO. Inc. Has $1.37 Million Stock Holdings in Profound Medical Corp. (NASDAQ:PROF)Thompson Davis & CO. Inc. raised its position in Profound Medical Corp. (NASDAQ:PROF - Free Report) by 78.9% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 182,295 shares of the company's stock after purchasing an additional 80,395 shares during the periFebruary 23, 2025 | marketbeat.comEquities Analysts Set Expectations for PROF FY2024 EarningsProfound Medical Corp. (NASDAQ:PROF - Free Report) - Stock analysts at Raymond James boosted their FY2024 EPS estimates for shares of Profound Medical in a note issued to investors on Tuesday, February 18th. Raymond James analyst M. Freeman now expects that the company will earn ($1.18) per shareFebruary 21, 2025 | marketbeat.comEquities Analysts Set Expectations for PROF Q1 EarningsProfound Medical Corp. (NASDAQ:PROF - Free Report) - Research analysts at Raymond James issued their Q1 2026 earnings estimates for shares of Profound Medical in a report released on Tuesday, February 18th. Raymond James analyst M. Freeman forecasts that the company will post earnings per share oFebruary 20, 2025 | marketbeat.comProfound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 – Conference Call to FollowFebruary 13, 2025 | financialpost.comProfound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 – Conference Call to FollowFebruary 13, 2025 | financialpost.comProfound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 – Conference Call to FollowFebruary 13, 2025 | globenewswire.comUMass Chan Medical School leader: NIH cuts are 'profound and sobering'February 11, 2025 | usatoday.comGagnon Advisors LLC Acquires 149,445 Shares of Profound Medical Corp. (NASDAQ:PROF)Gagnon Advisors LLC increased its holdings in shares of Profound Medical Corp. (NASDAQ:PROF - Free Report) by 20.0% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 896,671 shares of the company's stock after purchasing an additional 149,445 shares during the perFebruary 1, 2025 | marketbeat.comProfound Medical Corp. (NASDAQ:PROF) Shares Acquired by Gagnon Securities LLCGagnon Securities LLC boosted its stake in shares of Profound Medical Corp. (NASDAQ:PROF - Free Report) by 12.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,652,531 shares of the company'February 1, 2025 | marketbeat.comProfound Medical (NASDAQ:PROF) Trading Down 5.3% - Here's What HappenedProfound Medical (NASDAQ:PROF) Stock Price Down 5.3% - Here's What HappenedJanuary 30, 2025 | marketbeat.comProfound Medical’s announces reschedule of JPM conference presentationJanuary 14, 2025 | markets.businessinsider.comProfound Medical reports preliminary Q4 revenue $4.1M-$4.2M, consensus $6.09MJanuary 8, 2025 | markets.businessinsider.comProfound Medical Reports Robust Revenue Growth and Transition to U.S. GAAPJanuary 8, 2025 | tipranks.comProfound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 RevenuesJanuary 8, 2025 | globenewswire.comProfound Medical to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 6, 2025 | globenewswire.comA Mirror Version of Life Could End All Life on Earth, Scientists SayDecember 19, 2024 | msn.comProfound Medical Successfully Prices Public Offering to Boost Commercialization EffortsDecember 17, 2024 | markets.businessinsider.comFY2024 EPS Estimate for Profound Medical Lifted by AnalystProfound Medical Corp. (NASDAQ:PROF - Free Report) - Analysts at Raymond James upped their FY2024 earnings estimates for Profound Medical in a report released on Wednesday, December 11th. Raymond James analyst M. Freeman now anticipates that the company will post earnings of ($1.27) per share forDecember 16, 2024 | marketbeat.comProfound Medical Raises $40.25 Million in Public OfferingDecember 10, 2024 | tipranks.comProfound Medical Announces Closing of US$40.25 Million Underwritten Public Offering of Common SharesDecember 10, 2024 | globenewswire.comProfound Medical trading resumesDecember 7, 2024 | markets.businessinsider.comProfound Medical Announces Pricing of US$35 Million Underwritten Public Offering of Common SharesDecember 6, 2024 | globenewswire.comProfound Medical announces common share offering, no amount givenDecember 6, 2024 | markets.businessinsider.comProfound Medical Plans Public Share OfferingDecember 5, 2024 | tipranks.comProfound Medical and Siemens Healthineers to Offer a Complete Solution for MRI-guided Prostate TherapyDecember 2, 2024 | globenewswire.comConnor Clark & Lunn Investment Management Ltd. Invests $612,000 in Profound Medical Corp. (NASDAQ:PROF)Connor Clark & Lunn Investment Management Ltd. purchased a new stake in shares of Profound Medical Corp. (NASDAQ:PROF - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 76,900November 29, 2024 | marketbeat.comProfound Medical Announces Unveiling of New AI Software Module for TULSA ProcedureNovember 28, 2024 | msn.comProfound Medical to unveil third TULSA-AI module at RSNA 2024November 26, 2024 | markets.businessinsider.comProfound Medical to Unveil Next TULSA-AI® Module, ‘UA Alignment Assistant’November 26, 2024 | financialpost.com Remove Ads Get Profound Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for PROF and its competitors with MarketBeat's FREE daily newsletter. Email Address PROF Media Mentions By Week PROF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PROF News Sentiment▼0.730.62▲Average Medical News Sentiment PROF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PROF Articles This Week▼73▲PROF Articles Average Week Remove Ads Get Profound Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for PROF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AXGN News Today BVS News Today CBLL News Today EMBC News Today BFLY News Today IRMD News Today AVNS News Today BBNX News Today SIBN News Today KIDS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PROF) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Profound Medical Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Profound Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.